Hematologic features which may influence Rh immunization.

S P LUCIA; M L HUNT

Home/Archive/PubMed

PubMed · 15434714

Hematologic features which may influence Rh immunization.

S P LUCIA·M L HUNT

View original source ↗Export metadata ↓

Abstract

The biologic features which may influence Rh sensitization in the mother and hemolytic disease in the newborn are conditioned by the hereditary immunologic pattern of the subjects, the antigenic characteristic of the blood group specific substances, the character of the antibody responses, the inherent susceptibility to disease as a result of the immune mechanism, and the character and sequence of exposure to the antigenic substance. In respect to Rh-negative women, there appears to be a greater vulnerability to immunization among those of blood group A. In regard to the infant, the compatibility of the maternal-infant blood types and the part they play in the phenomenon of the competition of antigens may influence the occurrence of hemolytic disease in the newborn.

Explore related subjects

Antibodies Antibody Formation Antigens Blood Group Antigens Female Humans Immunization Infant, Newborn Rh-Hr Blood-Group System Vaccination ANTIGENS AND ANTIBODIES Rh FACTOR Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

S P LUCIA, M L HUNT. 1950. Hematologic features which may influence Rh immunization.. https://pubmed.ncbi.nlm.nih.gov/15434714/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2021

ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma.

In glioblastoma (GBM), the most frequent and lethal brain tumor, therapies suppressing recurrently altered signaling pathways failed to extend survival. However, in patient subsets, specific genetic lesions can confer sensitivity to targeted agents. By exploiting an integrated model based on patient-derived stem-like cells, faithfully recapitulating the original GBMs in vitro and in vivo, here, we identify a human GBM subset (∼9% of all GBMs) characterized by ERBB3 overexpression and nuclear accumulation. ERBB3 overexpression is driven by inheritable promoter methylation or post-transcriptional silencing of the oncosuppressor miR-205 and sustains the malignant phenotype. Overexpressed ERBB3 behaves as a specific signaling platform for fibroblast growth factor receptor (FGFR), driving PI3K/AKT/mTOR pathway hyperactivation, and overall metabolic upregulation. As a result, ERBB3 inhibition by specific antibodies is lethal for GBM stem-like cells and xenotransplants. These findings highlight a subset of patients eligible for ERBB3-targeted therapy.

Antibodies↗

PubMed2005

Biocompatibility of surfaces for antibody microarrays: design of macroporous silicon substrates.

Major efforts to develop antibody microarray technology to enable global proteome analysis to be performed in a facile manner are under way. In this process, the design and the properties of the substrate will play crucial roles. In the present study, we have developed novel, highly biocompatible solid supports for microarrays, using adsorbed recombinant human single-framework antibody fragments as probes. Several silicon-based supports, including planar silicon, micro- and macroporous silicon, and nitrocellulose-coated variants thereof, were designed and evaluated in a stepwise procedure. The surfaces were scored based on biocompatibility and probe binding capacity as judged by spot morphology, signal intensities, signal to noise ratios, dynamic range, sensitivity, and reproducibility. A set of five commercially available substrates, selected to represent a set of supports providing different surface and coupling chemistries, was used as reference surfaces. The results showed that several well-performing silicon-based supports could be designed; in particular, a nitrocellulose-coated macroporous variant, MAP3-NC7, received the highest scores. In comparison, MAP3-NC7 displayed properties equal to or better than those of the reference substrates. Taken together, designed surfaces based on silicon can undoubtedly meet the requirements of the next generation of solid supports for antibody microarrays.

Antibodies↗

PubMed2005

Detection of enantiomeric impurities in a simple membrane-based optical immunosensor.

Currently available methods for the detection of enantiomeric impurities generally require expensive and sophisticated instrumentation. Here, we describe a simple and inexpensive membrane-based chiral immunosensor that allows quantitative determination of chiral analytes up to an enantiomer excess of 99.9%. The experimental setup is based on a competitive reaction between the analyte and a biotin-derivatized analog for the binding sites of a stereoselective antibody, which is immobilized onto a membrane. The antibody-bound analog is detected with peroxidase-conjugated avidin that converts a colorless substrate into an insoluble dye on the membrane surface. The color intensity, which is inversely related to the concentration of analyte in a sample, can be evaluated with standard image analysis programs.

Antibodies↗